ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

18 links0 made here, not in the record19 judgments2 judges (the rules as one: Rule based)1 record change seen
Claude Opus 5.5Rule basedRecord updated on ClinicalTrials.gov
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT06532149ERectile Dysfunctions,gOnadotoxicity and SexualHealth Assessment in MenWith Lung CancerFondazione Policlinico UniversrecruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Nov 8 · ClinicalTrials.gov record · MeSH filing re-derivedMeSH filing re-derivedCONDITIONSCarcinoma, Non-Small-Cell L…The registry's MeSH filing›As of now · Rule based · Main conditionMain conditionSexual Dysfunction, Physiol…The registry's MeSH filing›No judgment recorded. Shown as the registry files it.EunuchismThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Erectile DysfunctionThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.DRUGSAlectinibIntervention entry›Nov 10 · Claude Opus 5.5 · ExposureNov 18 · Rule based · ExposureExposureBrigatinibIntervention entry›Nov 18 · Rule based · ExposureExposureLorlatinibEntry “Lorlatinib 100 mg”, read by ou…›Nov 18 · Rule based · ExposureExposureOsimertinibIntervention entry›Nov 3 · Claude Opus 5.5 · ExposureNov 18 · Rule based · ExposureExposureSotorasibIntervention entry›Nov 18 · Rule based · ExposureExposureDabrafenibIntervention entry›Nov 18 · Rule based · ExposureExposureTrametinibIntervention entry›Nov 18 · Rule based · ExposureExposureSelpercatinibIntervention entry›Nov 18 · Rule based · ExposureExposurePembrolizumabIntervention entry›Nov 1 · Claude Opus 5.5 · ExposureNov 18 · Rule based · ExposureExposureCemiplimabIntervention entry›Nov 18 · Rule based · ExposureExposureNivolumabIntervention entry›Nov 2 · Claude Opus 5.5 · ExposureNov 18 · Rule based · ExposureExposureCarboplatinIntervention entry›Nov 18 · Rule based · ExposureExposurePemetrexedIntervention entry›Nov 18 · Rule based · ExposureExposurePaclitaxelIntervention entry›Nov 18 · Rule based · ExposureExposure

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Alectinib

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “Alectinib”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Exposure
Exposure · 2

All judgments on this study

WhenLinkJudgeDecisionState
Nov 1PembrolizumabClaude Opus 5.5ExposureCurrent
Nov 2NivolumabClaude Opus 5.5ExposureCurrent
Nov 3OsimertinibClaude Opus 5.5ExposureCurrent
Nov 8The record itselfClinicalTrials.gov recordMeSH filing re-derivedRecord change
Nov 10AlectinibClaude Opus 5.5ExposureCurrent
Nov 18AlectinibRule based · role ruleExposureAgrees
Nov 18BrigatinibRule based · role ruleExposureCurrent
Nov 18LorlatinibRule based · role ruleExposureCurrent
Nov 18OsimertinibRule based · role ruleExposureAgrees
Nov 18SotorasibRule based · role ruleExposureCurrent
Nov 18DabrafenibRule based · role ruleExposureCurrent
Nov 18TrametinibRule based · role ruleExposureCurrent
Nov 18SelpercatinibRule based · role ruleExposureCurrent
Nov 18PembrolizumabRule based · role ruleExposureAgrees
Nov 18CemiplimabRule based · role ruleExposureCurrent
Nov 18NivolumabRule based · role ruleExposureAgrees
Nov 18CarboplatinRule based · role ruleExposureCurrent
Nov 18PemetrexedRule based · role ruleExposureCurrent
Nov 18PaclitaxelRule based · role ruleExposureCurrent
As of nowCarcinoma, Non-Small-Cell LungRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.